Podcasts about host john j

On our second episode of the new short-form TrueTunes@45RPM show, we bring you MORE Bruce Cockburn! Host John J. Thompson and singer/songwriter Chris Taylor continue their dive into 2 more favorites from Bruce: "Loner" and "Gospel of Bondage." For more info visit TrueTunes.com. Thanks to our sponsors at VisionTrust.org. You can support this show by joining our group of patrons at Patreon.com/truetunes or dropping us a tip via PayPal.  (Believe it or not, there was even MORE to this conversation, which has been sent to our Patreon backers separately.)  Don't miss the full show, and keep spreading the word! 

Host: John J. Russell, MD Guest: Jessica Malaty Rivera, MS Social media and the ability to quickly spread information across the internet has allowed misinformation surrounding COVID-19 vaccines and the disease itself to spread like wildfire. But the good news is that when armed with effective counseling strategies and data from initiatives like the COVID-19 Tracking Project, we as clinicians can help stop the spread of harmful conspiracies and myths. Joining Dr. John Russell to talk about those essential strategies and the COVID-19 Tracking Project is infectious disease epidemiologist Ms. Jessica Rivera.

Host: John J. Russell, MD The global pandemic incited the expedited development of COVID-19 vaccines. But how did that change the development process? ReachMD host and Family Medicine Physician, Dr. John Russell, tells us how the rollout of the COVID-19 vaccine differs from other vaccines and what it could mean for the medical field.

Host: John J. Russell, MD Guest: Greg Berry, MD We are at a time when COVID-19, respiratory syncytial virus, and the flu all pose serious risks. Quick and accurate diagnoses are vital to determining the correct patient pathway and minimizing viral spread. But what diagnostic challenges do we face, and how can we overcome them? Joining Dr. John Russell to discuss these respiratory testing challenges and Cepheid's 4-in-1 respiratory test is Dr. Greg Berry, Associate Director of the Center for Advanced Laboratory Medicine at the Columbia University Irving Medical Center in New York.

Host: John J. Russell, MD Guest: Paul Farmer, MD, PhD Dr. John Russell meets with Dr. Paul Farmer, the Chair of Global Health at Harvard Medical School and co-founder of Partners in Health, to review past pandemics and outbreaks while discussing things we can do as a community to lower the risk of these events.

Host John J. Thompson is back in the living room of writer, multi-instrumentalist, producer, and artist Phil Madeira (Emmylou Harris, Buddy Miller, John Scofield,) to talk about his recent solo projects, Providence, Crickets, Open Heart, and Hornet’s Nest as they wrap up this wide-ranging chat. The conversation gets into pretty deep waters right out of the gate, with Phil sharing some very vulnerable context about personal relationship challenges, the pain that came with the loss of a loved one, his own search for answers, and his commitment to staying true to his calling and how that has shaped his work as an artist. We’ll ruffle some feathers on this one, no doubt, but that’s what art is supposed to do, right?On the True Tunes Jukebox, we’ll take a deep dive into those recent solo albums, listening closely to some really interesting, and complicated, contemporary jazz-inflected Americana music and how it might help us find resolution in the midst of these complicated times. Full show notes are at TrueTunes.com - and don't miss the special corresponding "mixtape" curated by Madeira for this episode!Thanks to our sponsors - VisionTrust.org. Please consider sponsoring a child today.  

Host: John J. Russell, MD Guest: Adam Hill, MD Dr. John Russell is joined by Dr. Adam Hill, author of “Long Walk Out of the Woods,” to discuss depression among healthcare professionals and address trauma faced in the medical field.

Host: John J. Russell, MD Guest: Rose George Dr. John Russell is joined by Rose George, the author of the book “Nine Pints," to take an in-depth look into everything we know about blood.

Host: John J. Russell, MD Guest: Christopher Haines, MD, MA The COVID-19 pandemic has altered the field of medicine. To better understand the science behind this virus while putting this pandemic into historical perspective, Dr. Christopher Haines shares his experiences caring for patients during the pandemic and describes what drove him to write his book: COVID-19 Essays from the Front: The First Six Months.

Host: John J. Russell, MD Guest: William G. Callahan, DO The COVID-19 pandemic has compelled many to stay home, but for those venturing out, how can we encourage them to stay safe? Dr. Bill Callahan, a family physician at Abington Jefferson Health and outdoorsman, sits down with Dr. John Russell to discuss how to stay safe during this winter pandemic.

Host: John J. Russell, MD Guest: Philip J. Mease, MD Guest: April Armstrong, MD, MPH Of the more than eight million Americans living with psoriasis, up to 30 percent of them may go on to develop psoriatic arthritis (PsA). Dr. Philip Mease and Dr. April Armstrong are here to walk us through how physicians can provide multidisciplinary care for people living with this chronic condition. We’ll also hear from them about a treatment option available to adults with active PsA. This promotional educational activity is brought to you by Janssen Pharmaceuticals, Inc., and is not certified for continuing medical education. The consultants are paid speakers for Janssen Pharmaceuticals, Inc. The speakers are presenting on behalf of Janssen and must present information in compliance with FDA requirements applicable to Janssen. © Janssen Pharmaceuticals, Inc. 2020 12/20 cp-187500v1

Host: John J. Russell, MD Guest: Aaron Broadwell, MD Guest: Michelle Owen, Clinic Operations Manager Gaining access to treatment can be a complex process, and it is our job as healthcare professionals to help patients navigate through the steps and obtain the treatment they need. Dr. Aaron Broadwell and clinic operations manager Michelle Owen are here to discuss some of the common challenges patients face and things to consider when navigating the process. The consultants are paid speakers for Janssen Pharmaceuticals, Inc. The opinions shared in this segment are those of the paid speakers and may not be reflective of the larger population. © Janssen Pharmaceuticals, Inc. 2020 12/20 cp-185221v1

Host: John J. Russell, MD The practice of quarantining ill patients goes back much further than you may realize. Tune in as Dr. John Russell walks us through the history of quarantines going all the way back to the year 1200. Published April 21, 2020

Host: John J. Russell, MD In the absence of FDA-approved therapies and vaccines to battle the COVID-19 pandemic, healthcare professionals on the frontlines are turning to malarial medicines like chloroquine and hydroquinone to treat their patients—despite the fact that there's no evidence to support their use. But this isn't the first time that medicines have been used for a different purpose than what they were intended for, as Dr. John Russell explains. Published April 21, 2020

Host: John J. Russell, MD Throughout history, diseases have acquired names from geographical landmarks, the name of the organism, the anatomy impacted, and even the media. But some naming conventions have resulted in negative consequences, which is why the World Health Organization established best practices for naming novel diseases in 2015. Here to walk us through those guidelines and to give us a brief history of how some well-known diseases—including the COVID-19 pandemic the world is currently facing—gained their name is Dr. John Russell. Published April 21, 2020

Host: John J. Russell, MD Guest: Diane E Custer, MD As the COVID-19 pandemic continues to spread across our nation and the world, more and more patients are experiencing anxiety and depression. Joining Dr. John Russell to explain how we can console our patients—all while maintaining our own mental health along the way—is Dr. Diane Custer. Published April 8, 2020

Host: John J. Russell, MD Social distancing is surprisingly not a new concept in the United States. As our country geared up for World War I in 1918, social gatherings and parades to support the military were at an all-time high. But as feelings of patriotism spread at these events, so too did influenza. Join Dr. John Russell as he recounts The Tale of Two Cities: Philadelphia and St. Louis and how the spread of influenza was dramatically different between the two cities due to the actions each took to mitigate risk. Published March 28, 2020

Host: John J. Russell, MD Guest: Debbie Glidden, MSN, APRN-BC, CNN Guest: David Henner, DO When your patients with chronic kidney disease who are on hemodialysis are suffering from secondary hyperparathyroidism, also known as sHPT, what can you do? John Russell, MD sits down with two community nephrology professionals, David Henner, DO from Pittsfield, Massachusetts, and Debbie Glidden, MSN, APRN-BC, CNN from Orlando, Florida, to discuss just that. Learn what these clinicians did to treat sHPT before Parsabiv®, and how the arrival of Parsabiv® changed things for them, their practices, and their patients. This promotional, non-CME program is intended for US Health Care Professionals. David Henner, DO and Debbie Glidden, MSN, APRN-BC, CNN were paid a fee by Amgen for their participation in the program.

Host: John J. Russell, MD Guest: Abdul Abdellatif, MD, FASN Guest: Debbie Glidden, MSN, APRN-BC, CNN How can you control the administration of calcimimetics for your patients with chronic kidney disease who are on hemodialysis and suffering from secondary hyperparathyroidism, also known as sHPT? John Russell, MD sits down with two community nephrology professionals, Adbul Abdellatif, MD, FASN from Houston, Texas, and Debbie Glidden, MSN, APRN-BC, CNN from Orlando, Florida. They will be discussing a dosing practice involving oral cinacalcet and what alternatives they suggest for nephrologists who are concerned about controlling the administration of sHPT treatment in an approved fashion. This promotional, non-CME program is intended for US Health Care Professionals. Adbul Abdellatif, MD, FASN and Debbie Glidden, MSN, APRN-BC, CNN were paid a fee by Amgen for their participation in the program.

Host: John J. Russell, MD Guest: David Henner, DO Guest: Abdul Abdellatif, MD, FASN With the ever-increasing pace and pressures faced by nephrology professionals both in the office and at the dialysis center, how can you keep up? John Russell, MD welcomes two community nephrologists, David Henner, DO from Pittsfield, Massachusetts, and Adbul Abdellatif, MD, FASN from Houston, Texas, to talk about just that. Together, they explore how nephrologists are dealing with the changing landscape of nephrology and how a drug called Parsabiv® is playing a role in the important work they do. This promotional, non-CME program is intended for US Health Care Professionals. David Henner, DO and Adbul Abdellatif, MD, FASN were paid a fee by Amgen for their participation in the program.

Host: John J. Russell, MD Guest: Debbie Glidden, MSN, APRN-BC, CNN Guest: David Henner, DO When your patients with chronic kidney disease who are on hemodialysis are suffering from secondary hyperparathyroidism, also known as sHPT, what can you do? John Russell, MD sits down with two community nephrology professionals, David Henner, DO from Pittsfield, Massachusetts, and Debbie Glidden, MSN, APRN-BC, CNN from Orlando, Florida, to discuss just that. Learn what these clinicians did to treat sHPT before Parsabiv®, and how the arrival of Parsabiv® changed things for them, their practices, and their patients. This promotional, non-CME program is intended for US Health Care Professionals. David Henner, DO and Debbie Glidden, MSN, APRN-BC, CNN were paid a fee by Amgen for their participation in the program.

Host: John J. Russell, MD Guest: Abdul Abdellatif, MD, FASN Guest: Debbie Glidden, MSN, APRN-BC, CNN How can you control the administration of calcimimetics for your patients with chronic kidney disease who are on hemodialysis and suffering from secondary hyperparathyroidism, also known as sHPT? John Russell, MD sits down with two community nephrology professionals, Adbul Abdellatif, MD, FASN from Houston, Texas, and Debbie Glidden, MSN, APRN-BC, CNN from Orlando, Florida. They will be discussing a dosing practice involving oral cinacalcet and what alternatives they suggest for nephrologists who are concerned about controlling the administration of sHPT treatment in an approved fashion. This promotional, non-CME program is intended for US Health Care Professionals. Adbul Abdellatif, MD, FASN and Debbie Glidden, MSN, APRN-BC, CNN were paid a fee by Amgen for their participation in the program.

Host: John J. Russell, MD Guest: David Henner, DO Guest: Abdul Abdellatif, MD, FASN With the ever-increasing pace and pressures faced by nephrology professionals both in the office and at the dialysis center, how can you keep up? John Russell, MD welcomes two community nephrologists, David Henner, DO from Pittsfield, Massachusetts, and Adbul Abdellatif, MD, FASN from Houston, Texas, to talk about just that. Together, they explore how nephrologists are dealing with the changing landscape of nephrology and how a drug called Parsabiv® is playing a role in the important work they do. This promotional, non-CME program is intended for US Health Care Professionals. David Henner, DO and Adbul Abdellatif, MD, FASN were paid a fee by Amgen for their participation in the program.

Host: John J. Russell, MD Guest: Nabil Wasif, MD Image: Mayo Foundation For Medical Education and Research. All Rights Reserved. Short for hyperthermic intraperitoneal chemotherapy, HIPEC is a form of treatment for advanced cancers of the gastrointestinal tract, like metastatic appendix, colon, and ovarian cancers. And after a recent Mayo Clinic study investigated the survival rates of patients who received HIPEC, Dr. Nabil Wasif joins us to discuss the study’s results as well as the benefits and drawbacks of HIPEC. For more information about referring a patient to Mayo Clinic, please visit mayoclinic.org and for continuing medical education opportunities visit ce.mayo.edu.

Host: John J. Russell, MD Guest: Nabil Wasif, MD Image: Mayo Foundation For Medical Education and Research. All Rights Reserved. Short for hypothermic intraperitoneal chemotherapy, HIPEC is a form of treatment for advanced cancers of the gastrointestinal tract, like metastatic appendix, colon, and ovarian cancers. And after a recent Mayo Clinic study investigated the survival rates of patients who received HIPEC, Dr. Nabil Wasif joins us to discuss the study’s results as well as the benefits and drawbacks of HIPEC. For more information about referring a patient to Mayo Clinic, please visit mayoclinic.org and for continuing medical education opportunities visit ce.mayo.edu.

Host: John J. Russell, MD Guest: Axel Grothey, MD In recent years, researchers have been investigating the role of tumor sidedness in metastatic colorectal cancer, and here to walk us through the latest findings and their application to colorectal cancer care is Dr. Axel Grothey.

Host: John J. Russell, MD Guest: Axel Grothey, MD Since biomarker testing can aid in the creation of individualized treatment plans, Dr. Axel Grothey is here to provide his perspective on the current state of biomarker testing for colorectal cancer and how we can increase biomarker testing practices at the time of diagnosis.

Host: John J. Russell, MD Guest: Axel Grothey, MD Since colorectal cancer continues to be one of the most common—and lethal—cancers, it should come as no surprise that much research has focused on improving the way we prevent, detect, and treat it, and joining Dr. John Russell to talk about the current and emerging research avenues in colorectal cancer is Dr. Axel Grothey.

Host: John J. Russell, MD Guest: Axel Grothey, MD Since colorectal cancer continues to be one of the most common—and lethal—cancers, it should come as no surprise that much research has focused on improving the way we prevent, detect, and treat it, and joining Dr. John Russell to talk about the current and emerging research avenues in colorectal cancer is Dr. Axel Grothey.

Host: John J. Russell, MD Guest: Axel Grothey, MD In recent years, researchers have been investigating the role of tumor sidedness in metastatic colorectal cancer, and here to walk us through the latest findings and their application to colorectal cancer care is Dr. Axel Grothey.

Host: John J. Russell, MD Guest: Axel Grothey, MD Since biomarker testing can aid in the creation of individualized treatment plans, Dr. Axel Grothey is here to provide his perspective on the current state of biomarker testing for colorectal cancer and how we can increase biomarker testing practices at the time of diagnosis.

On this special episode of Curtain Call, Host John J. Filippelli and Kevin Sullivan recap some of their favorite moments from past guests. We hear from the likes of Alex Rodriguez to Michael Kay and much more. http://twitter.com/curtaincallyes

On this special episode of Curtain Call, Host John J. Filippelli and Kevin Sullivan recap some of their favorite moments from past guests. We hear from the likes of Alex Rodriguez to Michael Kay and much more. http://twitter.com/curtaincallyes

Host John J. Thompson talks with independent singer, songwriter Christa Wells and reflects on the latest album by Sam Phillips (World On Sticks) and the 1979 classic, Straight On, by DeGarmo and Key on the True Tunes Jukebox. Listeners also get a sneak peek at a song from the upcoming film Electric Jesus and a listen to a song from the very first performance by The 77s in 1979 (as The Scratch Band) in honor of their 40th Anniversary! 

Host: John J. Russell, MD Guest: Mark Sundermeyer, MD Early diagnosis of non-small cell lung cancer (NSCLC) can increase patients’ rate of survival, and primary care practitioners play an important role in this since they’re oftentimes on the frontlines of care. Here to discuss with Dr. John Russell how primary care practitioners like himself can expedite getting patients with NSCLC to treatment is oncologist Dr. Mark Sundermeyer. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Host: John J. Russell, MD Guest: Mark Sundermeyer, MD Early diagnosis of non-small cell lung cancer (NSCLC) can increase patients’ rate of survival, and primary care practitioners play an important role in this since they’re oftentimes on the frontlines of care. Here to discuss with Dr. John Russell how primary care practitioners like himself can expedite getting patients with NSCLC to treatment is oncologist Dr. Mark Sundermeyer. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Host: John J. Russell, MD Guest: Victoria Sweet, MD After her father was admitted to the hospital with a wrong diagnosis and consequently received the wrong treatment, Dr. Victoria Sweet found that no doctor would speak with her face to face. This eye-opening experience left her with the following question: What has gone missing from medicine? This became the motivation for her book, Slow Medicine: The Way to Healing. Dr. Sweet joins Dr. John Russell to divulge on the logic, love, and beauty of slowing down in healthcare.

Host: John J. Russell, MD Guest: Victoria Sweet, MD After her father was admitted to the hospital with a wrong diagnosis and consequently received the wrong treatment, Dr. Victoria Sweet found that no doctor would speak with her face to face. This eye-opening experience left her with the following question: What has gone missing from medicine? This became the motivation for her book, Slow Medicine: The Way to Healing. Dr. Sweet joins Dr. John Russell to divulge on the logic, love, and beauty of slowing down in healthcare.

Host: John J. Russell, MD Guest: Lee Reichman, MD, MPH To help us understand how primary care physicians can lead the way in proactively identifying and treating patients at high risk for TB, we caught up with Dr. Lee Reichman, Founding Executive Director of the Rutgers Global Tuberculosis Institute and Professor of Medicine and Epidemiology at Rutgers New Jersey Medical School.

Host: John J. Russell, MD Guest: Lee Reichman, MD, MPH To help us understand how primary care physicians can lead the way in proactively identifying and treating patients at high risk for TB, we caught up with Dr. Lee Reichman, Founding Executive Director of the Rutgers Global Tuberculosis Institute and Professor of Medicine and Epidemiology at Rutgers New Jersey Medical School.

Host: John J. Russell, MD Guest: Lee Reichman, MD, MPH To help us understand how primary care physicians can lead the way in proactively identifying and treating patients at high risk for TB, we caught up with Dr. Lee Reichman, Founding Executive Director of the Rutgers Global Tuberculosis Institute and Professor of Medicine and Epidemiology at Rutgers New Jersey Medical School.

Host: John J. Russell, MD Guest: Kate Moore During World War I, hundreds of young women—some as young as eleven—flocked to the clock factories, thrilled at the chance to land wartime work as radium-dial painters. Blended with historical and scientific significance, their personal stories are unveiled in Kate Moore's The Radium Girls: The Dark Story of America's Shining Women. Moore spares us no shelter from understanding the pain in which they were living and the fight they inevitably began.

Host: John J. Russell, MD Guest: Kate Moore During World War I, hundreds of young women—some as young as eleven—flocked to the clock factories, thrilled at the chance to land wartime work as radium-dial painters. Blended with historical and scientific significance, their personal stories are unveiled in Kate Moore's The Radium Girls: The Dark Story of America's Shining Women. Moore spares us no shelter from understanding the pain in which they were living and the fight they inevitably began.

Host: John J. Russell, MD Guest: J. Wesley Sublett, MD, MPH Guest: Nia Gandolfo Having a peanut allergy affects almost every aspect of your patient’s life, especially if they’re an adolescent. Learn more about what the real burden of this allergy is for patient Nia and her doctor J. Wesley Sublett of Family Allergy and Asthma in Louisville, Kentucky.

Host: John J. Russell, MD Guest: J. Wesley Sublett, MD, MPH Guest: Nia Gandolfo Having a peanut allergy affects almost every aspect of your patient’s life, especially if they’re an adolescent. Learn more about what the real burden of this allergy is for patient Nia and her doctor J. Wesley Sublett of Family Allergy and Asthma in Louisville, Kentucky.

Host: John J. Russell, MD Guest: J. Wesley Sublett, MD, MPH Guest: Nia Gandolfo Having a peanut allergy affects almost every aspect of your patient’s life, especially if they’re an adolescent. Learn more about what the real burden of this allergy is for patient Nia and her doctor J. Wesley Sublett of Family Allergy and Asthma in Louisville, Kentucky.

Host: John J. Russell, MD Guest: Henry A. Wojtczak, MD Allergic rhinitis (AR) and asthma are common allergic respiratory conditions. In fact, AR is a major factor in the development of asthma. Medical costs associated with these two conditions are high, but can be reduced considerably when following evidence-based diagnosis and treatment guidelines, which include allergy testing and avoidance of relevant allergens. The goal of this CME activity is to help clinicians understand the rationale for allergy testing for people with AR and asthma and incorporate the results from allergy testing into a comprehensive evidence-based treatment approach.

Host: John J. Russell, MD Guest: Sam Quinones Weaving together two classic tales of capitalism and the unintended collision laying waste to communities across the country, Sam Quinones, author of Dreamland, introduces an unforgettable cast of characters, including pharma pioneers, young Mexican entrepreneurs, narcotics investigators, survivors, and parents, to share what he believes is at the root of the opiate addiction epidemic.

Host: John J. Russell, MD Guest: Aaron Carroll, MD Over the years, the world of food has taken drastic swings, such as the demonization of butter in the '70s and today’s obsession with gluten-free foods to cut out carbs. Dr. Aaron Carroll, author of The Bad Food Bible: How and Why to Eat Sinfully, dives into the myths surrounding nutrition and why common sense might just be the answer to eating healthy.

Host: John J. Russell, MD Guest: Aaron Carroll, MD Over the years, the world of food has taken drastic swings, such as the demonization of butter in the '70s and today’s obsession with gluten-free foods to cut out carbs. Dr. Aaron Carroll, author of The Bad Food Bible: How and Why to Eat Sinfully, dives into the myths surrounding nutrition and why common sense might just be the answer to eating healthy.